Israel Englander’s iSpecimen ISPC Stock Holding History

Israel Englander’s Portfolio ISPC Stock Details ISPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-55	Closed	-$10.2K	–	6214
2024 Q1	$10.2K	Buy	55 +28	+104%	+$9.87K	﹤0.01%	5925
2023 Q4	$10.8K	Buy	+27	New	+$11.8K	﹤0.01%	5730
2021 Q4	–	Sell	-35	Closed	-$162K	–	7098
2021 Q3	$162K	Buy	+35	New	+$170K	﹤0.01%	6219

Other funds holding ISPC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Israel Englander's ISPC Position: Q2 2024 in Review

Israel Englander sold out of iSpecimen (ISPC) in Q2 2024, closing a stake of 55 shares — an estimated $10.2K sold.

Israel Englander first reported a position in ISPC in Q3 2021 and held it in 3 quarters. The position peaked at $162K in Q3 2021. 11 funds tracked by Wall St. Rank hold ISPC as of Q2 2024.

Israel Englander reported no remaining iSpecimen position as of Q2 2024 after selling out during the quarter.
Israel Englander sold 55 iSpecimen shares in Q2 2024, an estimated $10.2K.
Israel Englander first reported a position in iSpecimen in Q3 2021 and held it in 3 quarters.
Israel Englander's iSpecimen position peaked at $162K in Q3 2021.
11 funds tracked by Wall St. Rank held iSpecimen as of Q2 2024.

Based on Millennium Management's 13F filing for Q2 2024, filed 14 Aug 2024.